Home
|
Definition and funding of the European LeukemiaNet: The European LeukemiaNet is a publicly funded research network of excellence. Goal is cure of leukemia by integration of European leukemia research and spread of excellence. The website delivers information for physicians, researchers and the public on the disease, ongoing clinical trials, research projects and organizational matters. You can get information about the European LeukemiaNet in various European languages. The European LeukemiaNet was funded by the 6th Framework Program of the European Community until 2011, by the European Research Foundation until 2015 and is currently funded by the ELN-Foundation. |
||
|
|
|
|
|
Due to the corona pandemic, the next ELN Symposium is planned again in Mannheim, Congress Center Rosengarten on September 7, 2021.
On March 9, 2021 virtual ELN-WP-session are offered from 9:45 - 20:00 for the following WPs:
Virtual ELN WP Sessions 9.3.2021, 9:45 – 20:00
WP10 (Morphology, Flow Cytometry) Chair: Bené 9:45-11:15
WP4 (CML)/HARMONY PLUS) Chairs: Guilhot, Hochhaus, Stenke 11:30-13:00
ELN/HARMONY Chairs: Bullinger, Hernandez 13:15-14:45
WP9 (MPN) Chairs: Kiladjian, Koschmieder 15:00-16:30
WP8 (MDS) Chair: de Witte 16:45-18:15
WP14 (GvHD, Tranplantation Chairs: Niederwieser, Apperley, Basak, Mohty 18:30-20:00
European LeukemiaNet - Network info and goals
The objective of the European LeukemiaNet is to integrate the leading leukemia trial groups (CML, AML, ALL, CLL, MDS, CMPD), their interdisciplinary partners (diagnostics, treatment research, registry, guidelines), industry and SMEs across Europe to form a cooperative network for advancements in leukemia-related research and health care and cure.
Achievements ELN 2016-2018.pdf (436KB)
Achievements of the ELN
Achievements in addition to the integration of leukemia research among its more than 1000 physicians and researchers and 220 institutions are the more than 100 management recommendations and guidelines for all forms of leukemia and related interdisciplinary specialities. A selection of the most recent recommendations (2016-2018) is included in the attachment. We also list the publications by others which carry the European LeukemiaNet in their titles. The key instrument of integration are regular meetings, in particular the annual ELN symposium at no cost for participants.
Definition and funding of the European LeukemiaNet
The European LeukemiaNet is a publicly funded research network of excellence. Goal is cure of leukemia by integration of European leukemia research and spread of excellence. The website delivers information for physicians, researchers and the public on the disease, ongoing clinical trials, research projects and organizational matters. You can get information about the European LeukemiaNet in various European languages. The European LeukemiaNet was funded by the 6th Framework Program of the European Community until 2011, by the European Research Foundation until 2015 and is currently funded by the ELN-Foundation.
ELN Steering Committee (ELN SC)
ELN SC members:
Andreas Hochhaus
Claudia Haferlach
Detlef Haase
Dieter Hoelzer
Dietger Niederwieser
Eva Hellström-Lindberg
Emili Montserrat
Francois Guilhot
Gianni Barosi
Gert Ossenkoppele
Gina Zini
Hartmut Döhner
Hervé Dombret
Hermann Einsele
Harald Rieder
Hubert Serve
Torsten Haferlach
Jane Apperley
Jörg Hasford
Jean-Jacques Kiladjian
Jesus Hernandez
Josep Ribera
Michele Baccarani
Marie C. Bené
Martin Dugas
Michael Hallek
Miguel Sanz
Carsten Müller-Tidow
Nicola Gökbuget
Pierre Fenaux
Paolo Ghia
Per Ljungman
Heike Pahl
Renato Bassan
Rein Willemze
Robin Foa
Tiziana Barbui>
Theo de Witte
Christian Thiede
Leif Stenke
Giuseppe Saglio
Francois-Xavier Mahon
Hans-Jochem Kolb
Lars Bullinger
ELN-Coordinator:
Rüdiger Hehlmann
